characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling
about
Analysis of the lung microbiome in the "healthy" smoker and in COPDAirway microbiota and pathogen abundance in age-stratified cystic fibrosis patientsA polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patientsMembrane-bound nitrate reductase is required for anaerobic growth in cystic fibrosis sputumBacterial activity in cystic fibrosis lung infections.Republished: Respiratory microbiota: addressing clinical questions, informing clinical practiceMicrobiome and Asthma: What Have Experimental Models Already Taught Us?The pediatric microbiome and the lungCystic fibrosis therapy: a community ecology perspectiveCystic fibrosis therapeutics: the road aheadOxygen levels rapidly modulate Pseudomonas aeruginosa social behaviours via substrate limitation of PqsHThe extracellular matrix Component Psl provides fast-acting antibiotic defense in Pseudomonas aeruginosa biofilmsPyocyanina contributory factor in haem acquisition and virulence enhancement of Porphyromonas gingivalis in the lung [corrected]The airway microbiota in cystic fibrosis: a complex fungal and bacterial community--implications for therapeutic managementCulture enriched molecular profiling of the cystic fibrosis airway microbiomeChanges in cystic fibrosis airway microbial community associated with a severe decline in lung function.Contribution of Veillonella parvula to Pseudomonas aeruginosa-mediated pathogenicity in a murine tumor model system.Mechanistic model of Rothia mucilaginosa adaptation toward persistence in the CF lung, based on a genome reconstructed from metagenomic dataDetermining cystic fibrosis-affected lung microbiology: comparison of spontaneous and serially induced sputum samples by use of terminal restriction fragment length polymorphism profiling.Use of suppression-subtractive hybridization to identify genes in the Burkholderia cepacia complex that are unique to Burkholderia cenocepacia.Comparison of two fingerprinting techniques, terminal restriction fragment length polymorphism and automated ribosomal intergenic spacer analysis, for determination of bacterial diversity in aquatic environments.Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosis.Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients.Discerning the complexity of community interactions using a Drosophila model of polymicrobial infections.Studying bacteria in respiratory specimens by using conventional and molecular microbiological approachesMetagenomic analysis of respiratory tract DNA viral communities in cystic fibrosis and non-cystic fibrosis individuals.The role of the bacterial microbiome in lung diseaseAnalysis of the bacterial communities present in lungs of patients with cystic fibrosis from American and British centers.Ecological networking of cystic fibrosis lung infections.Partitioning core and satellite taxa from within cystic fibrosis lung bacterial communitiesReliability of quantitative real-time PCR for bacterial detection in cystic fibrosis airway specimensAntibiotic management of lung infections in cystic fibrosis. I. The microbiome, methicillin-resistant Staphylococcus aureus, gram-negative bacteria, and multiple infectionsPotentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma.Next-generation sequencing in the analysis of human microbiota: essential considerations for clinical application.The changing microbial epidemiology in cystic fibrosis.The metabolic footprint of the airway bacterial community in cystic fibrosis.True microbiota involved in chronic lung infection of cystic fibrosis patients found by culturing and 16S rRNA gene analysis.Effects of a composition containing lactoferrin and lactoperoxidase on oral malodor and salivary bacteria: a randomized, double-blind, crossover, placebo-controlled clinical trial.Comparison of bacterial communities in the throat swabs from healthy subjects and pharyngitis patients by terminal restriction fragment length polymorphism.Polymicrobial challenges to Koch's postulates: ecological lessons from the bacterial vaginosis and cystic fibrosis microbiomes.
P2860
Q21091065-3E934384-8686-4576-8C69-DB289698F096Q21562196-961B0465-B6D5-4B52-ACF0-7F69CC1D0284Q24652357-9B2BC8C3-9C4F-4E84-A161-BC238ED7EFACQ24678466-1A3270A3-DB5B-47B0-9C22-302F00E432BAQ24813737-2B95A605-2EB6-4BEB-94AB-81F1B102137DQ26797508-6BF32966-CC18-4152-BE95-0F55128319C3Q26798677-A5F63E51-2F9C-4685-8C12-68030C7AD67AQ26851334-ADCDA79B-CCBA-4534-B567-C099D1EE02FDQ27015964-3D4FAF43-BE80-4964-A792-C42978A39193Q27022401-58620286-50E0-4D5F-9F74-BE0475610D23Q28493027-C397068E-692D-41E3-9D92-54AC82B2CBAAQ28535199-CA23EABB-2992-4B6C-8B25-C7B385F366F2Q28543599-1CB13CCA-4B68-4A5E-B31B-2E446DDDECBAQ28730299-C11FE654-B633-4037-8C2C-A48108F74450Q28742049-5864DF30-DB1E-4881-BDC6-67A1686B7E2EQ30388877-6C12377F-EEEA-4B1F-BBA5-91615497D0D7Q30614122-B52CE1BB-04C5-41B3-B229-8793A2A9582EQ30641042-A0C8DEB6-EEAE-49FF-8015-7BE76C0DC410Q30882278-8F149CB2-352D-41D1-A1B7-7BE990CAAE88Q33219966-3F2FAF71-9F0A-4F57-850A-B3FFC5E86439Q33256611-860480B8-93AD-4F54-879E-5A0B9B86B915Q33310144-BC9E765B-003C-429A-9CBD-39741DC64A8AQ33358120-ACE7C549-0712-4748-8710-F4EE35B74411Q33379091-71BBC749-D873-493B-AED3-92278166DF52Q33430526-FC044C51-78FB-487D-9C06-30AEC377872FQ33509530-ECBE95CF-F032-4737-B6B7-9701FCFEA148Q33554623-3DA656B1-702F-4A0A-AF2B-90658B5FE2CEQ33743766-B2B0843E-0F7E-4542-B681-C083D460BA02Q33767505-43900C3B-D5B3-46A3-B675-EA48B9C3AAA1Q33768691-9DB6EC28-C43F-4373-89AE-4F33170B8DA1Q33770039-15B7E070-7C91-487E-A872-AB74D0A3AE02Q33786154-EC4F7AF2-71B2-43C1-914E-06973AEDBF3DQ33793577-B4D685DF-C538-4DC8-BCFC-64D818C3B860Q33806208-6CE0922E-1511-4356-85E6-34414849F2DEQ33825634-94D5882D-F4D0-46F5-B019-24A8CB96F1ECQ33861701-1FA9611B-037D-4AA8-A513-ACE8546D4DA7Q34051927-5298F262-5544-4A5F-8BE7-ED77D23A681AQ34118147-58538771-3F5F-4C70-BE5F-65E7AB248A37Q34155792-BCD86D36-72FB-461F-9C7A-EA9A8DE1A484Q34179233-C1B8E8E5-0740-4633-970E-8AA5F497CABF
P2860
characterization of bacterial community diversity in cystic fibrosis lung infections by use of 16s ribosomal DNA terminal restriction fragment length polymorphism profiling
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
characterization of bacterial ...... length polymorphism profiling
@en
characterization of bacterial ...... length polymorphism profiling.
@nl
type
label
characterization of bacterial ...... length polymorphism profiling
@en
characterization of bacterial ...... length polymorphism profiling.
@nl
prefLabel
characterization of bacterial ...... length polymorphism profiling
@en
characterization of bacterial ...... length polymorphism profiling.
@nl
P2093
P2860
P1476
characterization of bacterial ...... length polymorphism profiling
@en
P2093
D J Serisier
G B Rogers
M P Carroll
P M Hockey
P2860
P304
P356
10.1128/JCM.42.11.5176-5183.2004
P407
P577
2004-11-01T00:00:00Z